1
WGU D027 ADVANCED PATHOPHARMACOLOGICAL
FOUNDATIONS OA 2026/2027 | Objective Assessment
Review | 100% Correct Verified Answers | Pass
Guaranteed - A+ Graded
Section 1: Cellular Pathophysiology &
Pharmacodynamics/Pharmacokinetics (Q1-15)
Q1. A 58-year-old male suffers an acute myocardial infarction. Histology reveals cells
with intact membranes, shrunken cytoplasm, and nuclear fragmentation without
inflammation. Which type of cell death is described?
A. Necrosis
B. Apoptosis [CORRECT]
C. Autophagy
D. Pyroptosis
Rationale: Apoptosis is programmed cell death characterized by cell shrinkage,
nuclear fragmentation (karyorrhexis), chromatin condensation, and formation of
apoptotic bodies without an inflammatory response. Necrosis involves cell swelling,
membrane rupture, and inflammation. Pyroptosis is inflammatory programmed
death; autophagy is cellular recycling.
Correct Answer: B
Q2. A novel drug binds to the beta-adrenergic receptor and produces 80% of the
maximal response compared to norepinephrine. It is classified as:
A. A full agonist
B. A partial agonist [CORRECT]
C. A competitive antagonist
D. An inverse agonist
,2
Rationale: A partial agonist binds to a receptor and produces a submaximal
response compared to a full agonist, even when all receptors are occupied. A full
agonist produces 100% maximal response; an antagonist blocks the receptor without
activating it; an inverse agonist produces the opposite effect of an agonist.
Correct Answer: B
Q3. Atorvastatin is prescribed to a patient with hyperlipidemia. Which enzyme does
atorvastatin primarily inhibit?
A. Lipoprotein lipase
B. HMG-CoA reductase [CORRECT]
C. Acetylcholinesterase
D. Cyclooxygenase-2
Rationale: Statins, including atorvastatin, competitively inhibit HMG-CoA reductase,
the rate-limiting enzyme in hepatic cholesterol synthesis. This upregulates LDL
receptors and increases LDL clearance. Lipoprotein lipase hydrolyzes triglycerides;
acetylcholinesterase breaks down acetylcholine; COX-2 is inhibited by NSAIDs.
Correct Answer: B
Q4. A patient is prescribed nitroglycerin for angina. The provider instructs sublingual
administration rather than oral swallowing primarily to avoid:
A. Hepatic first-pass metabolism [CORRECT]
B. Gastric acid degradation
C. Renal tubular secretion
D. Pulmonary enzymatic inactivation
Rationale: Sublingual administration bypasses the hepatic first-pass effect, allowing
nitroglycerin to enter systemic circulation directly via sublingual veins. Oral
nitroglycerin undergoes extensive first-pass hepatic metabolism, yielding negligible
bioavailability.
Correct Answer: A
,3
Q5. A patient prescribed codeine for postoperative pain reports no analgesic effect.
Genetic testing reveals a CYP2D6 poor metabolizer phenotype. What is the
pharmacological explanation?
A. Codeine is metabolized to an inactive compound
B. Codeine requires CYP2D6 conversion to morphine for analgesia [CORRECT]
C. The patient has developed rapid tolerance to opioids
D. Codeine is excreted unchanged in poor metabolizers
Rationale: Codeine is a prodrug that requires CYP2D6-mediated O-demethylation to
produce morphine, its active analgesic metabolite. Poor metabolizers cannot
efficiently convert codeine to morphine, resulting in inadequate pain relief. Ultrarapid
metabolizers are at risk for toxicity.
Correct Answer: B
Q6. A patient with rheumatoid arthritis experiences joint pain and swelling. Which
inflammatory mediator is primarily responsible for vasodilation, increased vascular
permeability, and pain sensitization at the site of injury?
A. Interleukin-2
B. Histamine
C. Prostaglandins [CORRECT]
D. Complement C3a
Rationale: Prostaglandins (particularly PGE2) are potent mediators of vasodilation,
increased vascular permeability, and pain sensitization (hyperalgesia) during the
inflammatory response. While histamine causes vasodilation and permeability early,
prostaglandins sustain these effects and mediate pain. Interleukin-2 is a T-cell growth
factor; C3a is an anaphylatoxin.
Correct Answer: C
, 4
Q7. The therapeutic index (TI) of a drug is calculated as:
A. ED50 divided by TD50
B. TD50 divided by ED50 [CORRECT]
C. LD100 divided by ED100
D. ED99 divided by TD1
Rationale: The therapeutic index is defined as the ratio of the toxic dose to 50% of
the population (TD50) divided by the effective dose to 50% of the population (ED50).
A higher TI indicates a wider margin of safety between therapeutic and toxic effects.
Correct Answer: B
Q8. A 70-year-old male (weight 72 kg, SCr 1.3 mg/dL) has a calculated creatinine
clearance of approximately 52 mL/min. Based on this value, which statement is
accurate?
A. Normal renal function; no dose adjustments needed
B. Mild renal impairment; monitor electrolytes only
C. Moderate renal impairment; many drugs require dose adjustment [CORRECT]
D. End-stage renal disease; dialysis is immediately indicated
Rationale: A creatinine clearance of 52 mL/min falls within Stage 3 CKD (moderate
renal impairment, eGFR 30-59 mL/min/1.73m²). Many renally eliminated drugs (e.g.,
gabapentin, metformin, digoxin, certain antibiotics) require dose reduction or interval
prolongation at this level of renal function.
Correct Answer: C
Q9. A drug with a half-life of 6 hours is started at a fixed dose every 6 hours.
Approximately how long will it take to reach steady-state plasma concentration?
A. 6 hours
B. 12 hours
C. 24 hours
D. 30 hours [CORRECT]
WGU D027 ADVANCED PATHOPHARMACOLOGICAL
FOUNDATIONS OA 2026/2027 | Objective Assessment
Review | 100% Correct Verified Answers | Pass
Guaranteed - A+ Graded
Section 1: Cellular Pathophysiology &
Pharmacodynamics/Pharmacokinetics (Q1-15)
Q1. A 58-year-old male suffers an acute myocardial infarction. Histology reveals cells
with intact membranes, shrunken cytoplasm, and nuclear fragmentation without
inflammation. Which type of cell death is described?
A. Necrosis
B. Apoptosis [CORRECT]
C. Autophagy
D. Pyroptosis
Rationale: Apoptosis is programmed cell death characterized by cell shrinkage,
nuclear fragmentation (karyorrhexis), chromatin condensation, and formation of
apoptotic bodies without an inflammatory response. Necrosis involves cell swelling,
membrane rupture, and inflammation. Pyroptosis is inflammatory programmed
death; autophagy is cellular recycling.
Correct Answer: B
Q2. A novel drug binds to the beta-adrenergic receptor and produces 80% of the
maximal response compared to norepinephrine. It is classified as:
A. A full agonist
B. A partial agonist [CORRECT]
C. A competitive antagonist
D. An inverse agonist
,2
Rationale: A partial agonist binds to a receptor and produces a submaximal
response compared to a full agonist, even when all receptors are occupied. A full
agonist produces 100% maximal response; an antagonist blocks the receptor without
activating it; an inverse agonist produces the opposite effect of an agonist.
Correct Answer: B
Q3. Atorvastatin is prescribed to a patient with hyperlipidemia. Which enzyme does
atorvastatin primarily inhibit?
A. Lipoprotein lipase
B. HMG-CoA reductase [CORRECT]
C. Acetylcholinesterase
D. Cyclooxygenase-2
Rationale: Statins, including atorvastatin, competitively inhibit HMG-CoA reductase,
the rate-limiting enzyme in hepatic cholesterol synthesis. This upregulates LDL
receptors and increases LDL clearance. Lipoprotein lipase hydrolyzes triglycerides;
acetylcholinesterase breaks down acetylcholine; COX-2 is inhibited by NSAIDs.
Correct Answer: B
Q4. A patient is prescribed nitroglycerin for angina. The provider instructs sublingual
administration rather than oral swallowing primarily to avoid:
A. Hepatic first-pass metabolism [CORRECT]
B. Gastric acid degradation
C. Renal tubular secretion
D. Pulmonary enzymatic inactivation
Rationale: Sublingual administration bypasses the hepatic first-pass effect, allowing
nitroglycerin to enter systemic circulation directly via sublingual veins. Oral
nitroglycerin undergoes extensive first-pass hepatic metabolism, yielding negligible
bioavailability.
Correct Answer: A
,3
Q5. A patient prescribed codeine for postoperative pain reports no analgesic effect.
Genetic testing reveals a CYP2D6 poor metabolizer phenotype. What is the
pharmacological explanation?
A. Codeine is metabolized to an inactive compound
B. Codeine requires CYP2D6 conversion to morphine for analgesia [CORRECT]
C. The patient has developed rapid tolerance to opioids
D. Codeine is excreted unchanged in poor metabolizers
Rationale: Codeine is a prodrug that requires CYP2D6-mediated O-demethylation to
produce morphine, its active analgesic metabolite. Poor metabolizers cannot
efficiently convert codeine to morphine, resulting in inadequate pain relief. Ultrarapid
metabolizers are at risk for toxicity.
Correct Answer: B
Q6. A patient with rheumatoid arthritis experiences joint pain and swelling. Which
inflammatory mediator is primarily responsible for vasodilation, increased vascular
permeability, and pain sensitization at the site of injury?
A. Interleukin-2
B. Histamine
C. Prostaglandins [CORRECT]
D. Complement C3a
Rationale: Prostaglandins (particularly PGE2) are potent mediators of vasodilation,
increased vascular permeability, and pain sensitization (hyperalgesia) during the
inflammatory response. While histamine causes vasodilation and permeability early,
prostaglandins sustain these effects and mediate pain. Interleukin-2 is a T-cell growth
factor; C3a is an anaphylatoxin.
Correct Answer: C
, 4
Q7. The therapeutic index (TI) of a drug is calculated as:
A. ED50 divided by TD50
B. TD50 divided by ED50 [CORRECT]
C. LD100 divided by ED100
D. ED99 divided by TD1
Rationale: The therapeutic index is defined as the ratio of the toxic dose to 50% of
the population (TD50) divided by the effective dose to 50% of the population (ED50).
A higher TI indicates a wider margin of safety between therapeutic and toxic effects.
Correct Answer: B
Q8. A 70-year-old male (weight 72 kg, SCr 1.3 mg/dL) has a calculated creatinine
clearance of approximately 52 mL/min. Based on this value, which statement is
accurate?
A. Normal renal function; no dose adjustments needed
B. Mild renal impairment; monitor electrolytes only
C. Moderate renal impairment; many drugs require dose adjustment [CORRECT]
D. End-stage renal disease; dialysis is immediately indicated
Rationale: A creatinine clearance of 52 mL/min falls within Stage 3 CKD (moderate
renal impairment, eGFR 30-59 mL/min/1.73m²). Many renally eliminated drugs (e.g.,
gabapentin, metformin, digoxin, certain antibiotics) require dose reduction or interval
prolongation at this level of renal function.
Correct Answer: C
Q9. A drug with a half-life of 6 hours is started at a fixed dose every 6 hours.
Approximately how long will it take to reach steady-state plasma concentration?
A. 6 hours
B. 12 hours
C. 24 hours
D. 30 hours [CORRECT]
